Insulin Resistance in Nonalcoholic Fatty Liver Disease: A Case Control Study
NCT00637520 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 29
Last updated 2017-07-11
Summary
We hypothesize that insulin resistance is characteristic of nonalcoholic fatty liver disease as compared to age, gender, non-diabetic BMI-matched control subjects, both healthy and those with non-cirrhotic, non-steatotic liver disease.
Conditions
- Insulin Resistance
- Nonalcoholic Fatty Liver Disease
Sponsors & Collaborators
-
University of Florida
collaborator OTHER - lead OTHER
Principal Investigators
-
Manal F Abdelmalek, MD., MPH · Faculty Member
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2007-07-31
- Primary Completion
- 2013-03-29
- Completion
- 2017-04-13
Countries
- United States
Study Locations
More Related Trials
-
Postprandial VLDL-triglyceride Metabolism in Type 2 Diabetes Patients With and Without NAFLD
NCT05044130 ·Status: COMPLETED ·Phase: NA
-
Insulin Resistance Study
NCT00614757 ·Status: SUSPENDED ·Phase: NA
-
Short Term Intermittent Fasting and Insulin Resistance
NCT02420054 ·Status: UNKNOWN ·Phase: NA
-
Relation of Obesity With Frequency of Meals (MST 0557)
NCT00229255 ·Status: COMPLETED ·Phase: NA
-
Tissue Lipids and Insulin Resistance
NCT00483210 ·Status: WITHDRAWN ·Phase: NA
-
Effects of Macronutrients on Hepatic Lipids, Plasma Triglycerides, and Insulin Sensitivity
NCT00523562 ·Status: COMPLETED ·Phase: NA
-
Does Class of Dietary Fat Affect Insulin Resistance?
NCT01541592 ·Status: COMPLETED ·Phase: NA
-
Iron Reduction for the Treatment of Diabetes and Nonalcoholic Fatty Liver Disease
NCT03696797 ·Status: COMPLETED ·Phase: NA
-
Effects of Phlebotomy on Insulin Sensitivity in Insulin Resistance-associated Hepatic Iron Overload Patients
NCT01572818 ·Status: COMPLETED ·Phase: NA
-
Race Adiposity Interactions Regulate Mechanisms Determining Insulin Sensitivity
NCT03043235 ·Status: COMPLETED
-
Moderately Carbohydrate-restricted Diet to Treat NAFLD in Adolescents
NCT05268042 ·Status: RECRUITING ·Phase: NA
-
Evaluation of the Effects of a Low Free Sugar Diet in Patients With Nonalcoholic Fatty Liver Disease
NCT04369521 ·Status: UNKNOWN ·Phase: NA
-
Dietary Intervention for Low Free Sugars in Children With Non-alcoholic Fatty Liver Disease
NCT06579729 ·Status: COMPLETED ·Phase: NA
-
Effect of Fructose Reduction on Non-alcoholic Fatty Liver Disease (NAFLD) and Metabolic Syndrome in Overweight Children
NCT01306396 ·Status: UNKNOWN ·Phase: NA
-
Insulin Receptor Substrate 1 (IRS-1) Regulation in Insulin Resistance
NCT01240252 ·Status: COMPLETED ·Phase: PHASE1
-
Fat Induced Insulin Resistance and Atherosclerosis
NCT02348190 ·Status: COMPLETED ·Phase: NA
-
Insulin Resistance in Severely Obese Patients
NCT00275223 ·Status: COMPLETED
-
Liver Fat as a Dietary Target of the Chinese Medical Nutrition Therapy (CMNT) Diet for Treating Type 2 Diabetes With Nonalcoholic Fatty Liver Disease
NCT05439226 ·Status: RECRUITING ·Phase: NA
-
Dietary Fatty Acid Composition and Obesity-related Metabolic Abnormalities
NCT01451970 ·Status: COMPLETED ·Phase: NA
-
Factors Involved in Obesity-related Inflammation and Insulin Resistance
NCT01173705 ·Status: TERMINATED
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
NCT05165706 ·Status: RECRUITING ·Phase: NA
-
Defining the Human Insulin Resistance Molecular Network; SIGNATURE
NCT07255807 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Liver Fat as a Dietary Target for Treating Cardiometabolic Disorders in Prediabetes and Type 2 Diabetes
NCT04527965 ·Status: COMPLETED ·Phase: NA
-
Effect of Timed-Restricted Eating on Metabolic Health
NCT06061042 ·Status: RECRUITING ·Phase: NA
-
Association Between Insulin Resistance and Beta Cell Function With HbA1C in Diabetics
NCT03196154 ·Status: COMPLETED